These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Invadopodia and rolling-type motility are specific features of highly invasive p190(bcr-abl) leukemic cells. Daubon T; Rochelle T; Bourmeyster N; Génot E Eur J Cell Biol; 2012; 91(11-12):978-87. PubMed ID: 22717125 [TBL] [Abstract][Full Text] [Related]
4. Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24 homology domains but not the pleckstrin homology one. Martinelli G; Amabile M; Giannini B; Terragna C; Ottaviani E; Soverini S; Saglio G; Rosti G; Baccarani M Haematologica; 2002 Jul; 87(7):688-94; discussion 694. PubMed ID: 12091118 [TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells. LaMontagne KR; Hannon G; Tonks NK Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14094-9. PubMed ID: 9826659 [TBL] [Abstract][Full Text] [Related]
6. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia]. Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985 [TBL] [Abstract][Full Text] [Related]
7. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells. Campbell ML; Li W; Arlinghaus RB Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598 [TBL] [Abstract][Full Text] [Related]
8. The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation. Sahay S; Pannucci NL; Mahon GM; Rodriguez PL; Megjugorac NJ; Kostenko EV; Ozer HL; Whitehead IP Oncogene; 2008 Mar; 27(14):2064-71. PubMed ID: 17922031 [TBL] [Abstract][Full Text] [Related]
9. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells. Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053 [TBL] [Abstract][Full Text] [Related]
10. NDPK-D (NM23-H4)-mediated externalization of cardiolipin enables elimination of depolarized mitochondria by mitophagy. Kagan VE; Jiang J; Huang Z; Tyurina YY; Desbourdes C; Cottet-Rousselle C; Dar HH; Verma M; Tyurin VA; Kapralov AA; Cheikhi A; Mao G; Stolz D; St Croix CM; Watkins S; Shen Z; Li Y; Greenberg ML; Tokarska-Schlattner M; Boissan M; Lacombe ML; Epand RM; Chu CT; Mallampalli RK; Bayır H; Schlattner U Cell Death Differ; 2016 Jul; 23(7):1140-51. PubMed ID: 26742431 [TBL] [Abstract][Full Text] [Related]
11. [Stable interference on P210(bcr/abl) gene expression by lentiviral vector-delivered shRNA in vitro and in vivo]. Zhu YF; Wang YZ; Meng FY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1090-4. PubMed ID: 23114125 [TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377 [TBL] [Abstract][Full Text] [Related]
13. PGAM5 regulates PINK1/Parkin-mediated mitophagy via DRP1 in CCCP-induced mitochondrial dysfunction. Park YS; Choi SE; Koh HC Toxicol Lett; 2018 Mar; 284():120-128. PubMed ID: 29241732 [TBL] [Abstract][Full Text] [Related]
14. The Dbl homology domain of BCR is not a simple spacer in P210BCR-ABL of the Philadelphia chromosome. Kin Y; Li G; Shibuya M; Maru Y J Biol Chem; 2001 Oct; 276(42):39462-8. PubMed ID: 11502748 [TBL] [Abstract][Full Text] [Related]
15. Influence of BCR/ABL fusion proteins on the course of Ph leukemias. Telegeev GD; Dubrovska AN; Dybkov MV; Maliuta SS Acta Biochim Pol; 2004; 51(3):845-9. PubMed ID: 15448745 [TBL] [Abstract][Full Text] [Related]
16. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells. Gross AW; Ren R Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343 [TBL] [Abstract][Full Text] [Related]
17. p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase. Brusa G; Benvenuti M; Mazzacurati L; Mancini M; Pattacini L; Martinelli G; Barbieri E; Greenberger JS; Baccarani M; Santucci MA Haematologica; 2003 Jun; 88(6):622-30. PubMed ID: 12801837 [TBL] [Abstract][Full Text] [Related]
18. Enhancement of imatinib-induced apoptosis of BCR/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway. Kurosu T; Wu N; Oshikawa G; Kagechika H; Miura O Apoptosis; 2010 May; 15(5):608-20. PubMed ID: 20094798 [TBL] [Abstract][Full Text] [Related]
19. Subcellular distribution of p210(BCR-ABL) in CML cell lines and primary CD34+ CML cells. Patel H; Marley SB; Greener L; Gordon MY Leukemia; 2008 Mar; 22(3):559-71. PubMed ID: 18059481 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Matulonis U; Salgia R; Okuda K; Druker B; Griffin JD Exp Hematol; 1993 Oct; 21(11):1460-6. PubMed ID: 8405226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]